Mark James Litton
CIK 1604834 · PRESIDENT and CEO · last filed 2026-04-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALDR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA 98011
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LONA | PRESIDENT and CEO | 59,894 | $2.38 | $142.5K | -$27.7K | 2 | 2026-04-13 |
| LeonaBio, Inc. (ATHA) Delisted | President and CEO | 42,796 | $6.92 | $296.1K | -$91.6K | 17 | 2026-01-05 |
| ALPINE IMMUNE SCIENCES, INC. (ALPN) Delisted | See Remarks | — | $64.97 | — | $0 | 2 | 2019-02-08 |
| ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Chief Business Officer | 132,663 | — | — | -$5.53M | 21 | 2018-06-05 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| LONA | Direct | 57,926 | 96.7% | 2026-03-05 |
| By Irrevocable Trust of SWL | 656 | 1.1% | 2026-03-05 | |
| By Irrevocable Trust of OSL | 656 | 1.1% | 2026-03-05 | |
| By Irrevocable Trust of WGL | 656 | 1.1% | 2026-03-05 | |
| Total | 59,894 | |||
| ATHA | Direct | 40,828 | 95.4% | 2026-01-05 |
| By Irrevocable Trust of SWL | 656 | 1.5% | 2026-01-05 | |
| By Irrevocable Trust of OSL | 656 | 1.5% | 2026-01-05 | |
| By Irrevocable Trust of WGL | 656 | 1.5% | 2026-01-05 | |
| Total | 42,796 | |||
| ALDR | Direct | 106,663 | 80.4% | 2018-06-05 |
| Held in trust for the benefit of Reporting Person's minor child | 26,000 | 19.6% | 2018-06-05 | |
| Total | 132,663 |
Recent Filings · Page 5 of 5
46 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-06 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Sell (S) | −7,500 | -$383.2K | EDGAR |
| 2015-06-08 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | — | -$1.10M | EDGAR |
| 2015-04-03 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Sell (S) | −7,500 | -$205.6K | EDGAR |
| 2015-01-28 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Mixed | −7,500 | -$211.3K | EDGAR |
| 2014-11-24 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Sell (S) | −30,000 | -$469.0K | EDGAR |
| 2014-07-10 | ALDER BIOPHARMACEUTICALS INC (ALDR) Delisted | Grant (A) | — | $0 | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).
Sales Reported Only on Form 144
1 sale · $17.8K| Sold | Symbol | Shares | Proceeds | Avg Price | Listed On |
|---|---|---|---|---|---|
| 2026-01-02 | LONA | 2,586 | $17.8K | $6.88 | 2026-03-04 |